Found: 24
Select item for more details and to access through your institution.
Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 209, doi. 10.1007/s00280-010-1297-x
- By:
- Publication type:
- Article
Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 219, doi. 10.1007/s00280-009-1149-8
- By:
- Publication type:
- Article
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 229, doi. 10.1007/s00280-009-1150-2
- By:
- Publication type:
- Article
Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 237, doi. 10.1007/s00280-009-1151-1
- By:
- Publication type:
- Article
Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 245, doi. 10.1007/s00280-009-1153-z
- By:
- Publication type:
- Article
Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 255, doi. 10.1007/s00280-009-1158-7
- By:
- Publication type:
- Article
Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 265, doi. 10.1007/s00280-009-1159-6
- By:
- Publication type:
- Article
Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 269, doi. 10.1007/s00280-009-1160-0
- By:
- Publication type:
- Article
Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 277, doi. 10.1007/s00280-009-1161-z
- By:
- Publication type:
- Article
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 287, doi. 10.1007/s00280-009-1162-y
- By:
- Publication type:
- Article
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 295, doi. 10.1007/s00280-009-1163-x
- By:
- Publication type:
- Article
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 303, doi. 10.1007/s00280-009-1164-9
- By:
- Publication type:
- Article
Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 315, doi. 10.1007/s00280-009-1165-8
- By:
- Publication type:
- Article
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 325, doi. 10.1007/s00280-009-1166-7
- By:
- Publication type:
- Article
Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Can the 2-<sup>13</sup>C-uracil breath test be used to predict the effect of the antitumor drug S-1?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 333, doi. 10.1007/s00280-009-1168-5
- By:
- Publication type:
- Article
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 345, doi. 10.1007/s00280-009-1169-4
- By:
- Publication type:
- Article
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 357, doi. 10.1007/s00280-009-1170-y
- By:
- Publication type:
- Article
Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 373, doi. 10.1007/s00280-009-1171-x
- By:
- Publication type:
- Article
Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 381, doi. 10.1007/s00280-009-1174-7
- By:
- Publication type:
- Article
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 389, doi. 10.1007/s00280-009-1175-6
- By:
- Publication type:
- Article
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.
- Published in:
- 2010
- By:
- Publication type:
- Report
Do 5-fluorouracil therapies alter CYP2C19 metaboliser status?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 405, doi. 10.1007/s00280-010-1277-1
- By:
- Publication type:
- Article
Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 409, doi. 10.1007/s00280-010-1291-3
- By:
- Publication type:
- Article